Found: 140
Select item for more details and to access through your institution.
Prognostic implication of serum hepatocyte growth factor in stage II/III breast cancer patients who received neoadjuvant chemotherapy.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2016, v. 142, n. 3, p. 707, doi. 10.1007/s00432-015-2072-5
- By:
- Publication type:
- Article
Nomogram predicting clinical outcomes in breast cancer patients treated with neoadjuvant chemotherapy.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2011, v. 137, n. 9, p. 1301, doi. 10.1007/s00432-011-0991-3
- By:
- Publication type:
- Article
Combination of chemotherapy and focused ultrasound for the treatment of unresectable pancreatic cancer: a proof-of-concept study.
- Published in:
- European Radiology, 2023, v. 33, n. 4, p. 2620, doi. 10.1007/s00330-022-09271-8
- By:
- Publication type:
- Article
Multiparametric fully-integrated 18-FDG PET/MRI of advanced gastric cancer for prediction of chemotherapy response: a preliminary study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Role of Adjuvant Chemoradiotherapy for Duodenal Cancer: An Updated Analysis of Long-Term Follow-Up from Single Institution.
- Published in:
- World Journal of Surgery, 2018, v. 42, n. 10, p. 3294, doi. 10.1007/s00268-018-4692-9
- By:
- Publication type:
- Article
Prognostic significance of tumour location after adjuvant chemoradiotherapy for periampullary adenocarcinoma.
- Published in:
- Clinical & Translational Oncology, 2012, v. 14, n. 5, p. 391, doi. 10.1007/s12094-012-0814-2
- By:
- Publication type:
- Article
A phase II trial of S-1 and oxaliplatin in patients with advanced hepatocellular carcinoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Prognostic role of body mass index is different according to menopausal status and tumor subtype in breast cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 176, n. 2, p. 453, doi. 10.1007/s10549-019-05249-1
- By:
- Publication type:
- Article
Prognostic effects of abnormal DNA damage response protein expression in breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 175, n. 1, p. 117, doi. 10.1007/s10549-019-05128-9
- By:
- Publication type:
- Article
A randomized, multicenter, phase II/III study to determine the optimal dose and to evaluate the efficacy and safety of pegteograstim (GCPGC) on chemotherapy-induced neutropenia compared to pegfilgrastim in breast cancer patients: KCSG PC10-09.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Everolimus in Neuroendocrine Tumors of the Gastrointestinal Tract and Unknown Primary.
- Published in:
- Neuroendocrinology, 2018, v. 106, n. 3, p. 211, doi. 10.1159/000477585
- By:
- Publication type:
- Article
Prognostic value of the TP53 mutation in patients with pancreatic ductal adenocarcinoma receiving FOLFIRINOX.
- Published in:
- Therapeutic Advances in Medical Oncology, 2024, p. 1, doi. 10.1177/17588359241290482
- By:
- Publication type:
- Article
Evaluation of Minimal Important Difference and Responder Definition in the EORTC QLQ-PAN26 Module for Assessing Health-Related Quality of Life in Patients with Surgically Resected Pancreatic Adenocarcinoma.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2021, v. 28, n. 12, p. 7545, doi. 10.1245/s10434-021-09816-z
- By:
- Publication type:
- Article
Is There Any Role of Adjuvant Chemotherapy for T3N0M0 or T1N2M0 Gastric Cancer Patients in Stage II in the 7th TNM but Stage I in the 6th TNM System?
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2016, v. 23, n. 4, p. 1234, doi. 10.1245/s10434-015-4980-7
- By:
- Publication type:
- Article
KRAS Mutation is Associated with Worse Prognosis in Stage III or High-risk Stage II Colon Cancer Patients Treated with Adjuvant FOLFOX.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2015, v. 22, n. 1, p. 187, doi. 10.1245/s10434-014-3826-z
- By:
- Publication type:
- Article
Clinical Usefulness of AJCC Response Criteria for Neoadjuvant Chemotherapy in Breast Cancer.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2013, v. 20, n. 7, p. 2242, doi. 10.1245/s10434-012-2756-x
- By:
- Publication type:
- Article
Ki-67 Expression Gives Additional Prognostic Information on St. Gallen 2007 and Adjuvant! Online Risk Categories in Early Breast Cancer.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2009, v. 16, n. 5, p. 1112, doi. 10.1245/s10434-009-0334-7
- By:
- Publication type:
- Article
Evaluation of the willingness-to-pay for cancer treatment in Korean metastatic breast cancer patients: A multicenter, cross-sectional study.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2012, v. 8, n. 3, p. 282, doi. 10.1111/j.1743-7563.2012.01546.x
- By:
- Publication type:
- Article
A phase I study of IMC-001, a PD-L1 blocker, in patients with metastatic or locally advanced solid tumors.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 6, p. 1624, doi. 10.1007/s10637-021-01078-6
- By:
- Publication type:
- Article
A first-in-human phase I study of TAS0728, an oral covalent binding inhibitor of HER2, in patients with advanced solid tumors with HER2 or HER3 aberrations.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 5, p. 1324, doi. 10.1007/s10637-021-01104-7
- By:
- Publication type:
- Article
Change in carbohydrate antigen 19-9 level as a prognostic marker of overall survival in locally advanced pancreatic cancer treated with concurrent chemoradiotherapy.
- Published in:
- International Journal of Clinical Oncology, 2017, v. 22, n. 6, p. 1069, doi. 10.1007/s10147-017-1129-7
- By:
- Publication type:
- Article
Ramucirumab plus paclitaxel as second-line treatment in patients with advanced gastric or gastroesophageal junction adenocarcinoma: a nationwide real-world outcomes in Korea study (KCSG-ST19-16).
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211042812
- By:
- Publication type:
- Article
Ramucirumab plus paclitaxel as second-line treatment in patients with advanced gastric or gastroesophageal junction adenocarcinoma: a nationwide real-world outcomes in Korea study (KCSG-ST19-16).
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211042812
- By:
- Publication type:
- Article
Real-world efficacy and safety of liposomal irinotecan plus fluorouracil/leucovorin in patients with metastatic pancreatic adenocarcinoma: a study by the Korean Cancer Study Group.
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. 1, doi. 10.1177/1758835919871126
- By:
- Publication type:
- Article
Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index.
- Published in:
- PLoS ONE, 2015, v. 10, n. 10, p. 1, doi. 10.1371/journal.pone.0139749
- By:
- Publication type:
- Article
Targeted Sequencing of Cancer-Related Genes in Colorectal Cancer Using Next-Generation Sequencing
- Published in:
- PLoS ONE, 2013, v. 8, n. 5, p. 1, doi. 10.1371/journal.pone.0064271
- By:
- Publication type:
- Article
Perceived needs for the information communication technology (ICT)-based personalized health management program, and its association with information provision, health-related quality of life (HRQOL), and decisional conflict in cancer patients.
- Published in:
- 2017
- By:
- Publication type:
- journal article
DNA methyltransferase 3B mutant in ICF syndrome interacts non-covalently with SUMO-1.
- Published in:
- Journal of Molecular Medicine, 2008, v. 86, n. 11, p. 1269, doi. 10.1007/s00109-008-0392-5
- By:
- Publication type:
- Article
Trastuzumab Specific Epitope Evaluation as a Predictive and Prognostic Biomarker in Gastric Cancer Patients.
- Published in:
- Biomolecules (2218-273X), 2019, v. 9, n. 12, p. 782, doi. 10.3390/biom9120782
- By:
- Publication type:
- Article
Results from a Phase 1b/2 Study of Ibrutinib Combination Therapy in Advanced Urothelial Carcinoma.
- Published in:
- Cancers, 2023, v. 15, n. 11, p. 2978, doi. 10.3390/cancers15112978
- By:
- Publication type:
- Article
TDP1 and TOP1 Modulation in Olaparib-Resistant Cancer Determines the Efficacy of Subsequent Chemotherapy.
- Published in:
- Cancers, 2020, v. 12, n. 2, p. 334, doi. 10.3390/cancers12020334
- By:
- Publication type:
- Article
Ibrutinib combination therapy for advanced gastrointestinal and genitourinary tumours: results from a phase 1b/2 study.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11539-1
- By:
- Publication type:
- Article
The prognostic role of soluble transforming growth factor‐β and its correlation with soluble programmed death‐ligand 1 in biliary tract cancer.
- Published in:
- Liver International, 2021, v. 41, n. 2, p. 388, doi. 10.1111/liv.14636
- By:
- Publication type:
- Article
The irreversible pan-HER inhibitor PF00299804 alone or combined with gemcitabine has an antitumor effect in biliary tract cancer cell lines.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 6, p. 2148, doi. 10.1007/s10637-011-9782-6
- By:
- Publication type:
- Article
Down-regulation of P-cadherin with PF-03732010 inhibits cell migration and tumor growth in gastric cancer.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 4, p. 1404, doi. 10.1007/s10637-011-9710-9
- By:
- Publication type:
- Article
A phase II trial of erlotinib in combination with gemcitabine and capecitabine in previously untreated metastatic/recurrent pancreatic cancer: combined analysis with translational research.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 3, p. 1164, doi. 10.1007/s10637-011-9651-3
- By:
- Publication type:
- Article
Loss of ataxia-telangiectasia-mutated protein expression correlates with poor prognosis but benefits from anthracycline-containing adjuvant chemotherapy in breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2016, v. 158, n. 2, p. 233, doi. 10.1007/s10549-016-3869-x
- By:
- Publication type:
- Article
Estrogen receptor status confers a distinct pattern of response to neoadjuvant chemotherapy: implications for optimal durations of therapy.
- Published in:
- Breast Cancer Research & Treatment, 2012, v. 134, n. 3, p. 1133, doi. 10.1007/s10549-012-2145-y
- By:
- Publication type:
- Article
The value of preoperative staging chest computed tomography to detect asymptomatic lung and liver metastasis in patients with primary breast carcinoma.
- Published in:
- Breast Cancer Research & Treatment, 2011, v. 126, n. 3, p. 637, doi. 10.1007/s10549-011-1368-7
- By:
- Publication type:
- Article
High serum TGF-α predicts poor response to lapatinib and capecitabine in HER2-positive breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2011, v. 125, n. 1, p. 107, doi. 10.1007/s10549-010-1200-9
- By:
- Publication type:
- Article
Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy.
- Published in:
- Breast Cancer Research & Treatment, 2009, v. 116, n. 1, p. 153, doi. 10.1007/s10549-008-0160-9
- By:
- Publication type:
- Article
Weight changes after adjuvant treatment in Korean women with early breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2009, v. 114, n. 1, p. 147, doi. 10.1007/s10549-008-9984-6
- By:
- Publication type:
- Article
Genetic and immune microenvironment characterization of HER2‐positive gastric cancer: Their association with response to trastuzumab‐based treatment.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 9, p. 10371, doi. 10.1002/cam4.5769
- By:
- Publication type:
- Article
Tolerability and efficacy of durvalumab, either as monotherapy or in combination with tremelimumab, in patients from Asia with advanced biliary tract, esophageal, or head‐and‐neck cancer.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 13, p. 2550, doi. 10.1002/cam4.4593
- By:
- Publication type:
- Article
The prognostic role of soluble TGF‐beta and its dynamics in unresectable pancreatic cancer treated with chemotherapy.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 1, p. 43, doi. 10.1002/cam4.2677
- By:
- Publication type:
- Article
Prognostic implications of soluble programmed death-ligand 1 and its dynamics during chemotherapy in unresectable pancreatic cancer.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-47330-1
- By:
- Publication type:
- Article
Real-world efficacy and safety of liposomal irinotecan plus fluorouracil/leucovorin in patients with metastatic pancreatic adenocarcinoma: a study by the Korean Cancer Study Group.
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. N.PAG, doi. 10.1177/1758835919871126
- By:
- Publication type:
- Article
Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis.
- Published in:
- Breast Cancer Research, 2011, v. 13, n. 1, p. 1, doi. 10.1186/bcr2834
- By:
- Publication type:
- Article
Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Adjuvant and Neoadjuvant Therapy for Gastric Cancer.
- Published in:
- Current Treatment Options in Oncology, 2013, v. 14, n. 3, p. 311, doi. 10.1007/s11864-013-0238-4
- By:
- Publication type:
- Article